Price, Stacey
Bhosle, Shriram
Gonçalves, Emanuel
Li, Xiaodun
McClurg, Dylan P.
Barthorpe, Syd
Beck, Alex
Hall, Caitlin
Lightfoot, Howard
Farrow, Luke
Ansari, Rizwan
Jackson, David A.
Allen, Laura
Roberts, Kirsty
Beaver, Charlotte
Francies, Hayley E.
Garnett, Mathew J.
Funding for this research was provided by:
Wellcome Trust (206194, 206194, 206194, 206194, 206194, 206194, 206194, 206194, 206194, 206194, 206194, 206194, 206194, 206194, 206194)
Medical Research Council (RG84369, RG84369)
Article History
Received: 19 August 2021
Accepted: 15 March 2022
First Online: 2 April 2022
Competing interests
: M.J.G. has received research funding from GlaxoSmithKline, Astex Pharmaceuticals and AstraZeneca, and is co-Founder and Chief Scientific Officer for Mosaic Therapeutics. M.J.G., S.P. and H.F. hold a patent application related to this study (GB2009808.3). All other authors declare no competing interests.